133473-26-4Relevant articles and documents
Photodemethylation of Methoxy-Substituted 9,10-Anthraquinones in Methanol
Blankespoor, Ronald L.,Hsung, Richard,Schutt, David L.
, p. 2877 - 2878 (1988)
Irradiation of methoxy-substituted 9,10-anthraquinones with visible or ultraviolet light results in a demethylation reaction involving free radical intermediates.
CoPd Nanoalloys with Metal–Organic Framework as Template for Both N-Doped Carbon and Cobalt Precursor: Efficient and Robust Catalysts for Hydrogenation Reactions
Zhu, Jie,Xu, Deng,Ding, Lu-jia,Wang, Peng-cheng
, p. 2707 - 2716 (2021/01/21)
In this work, a series of metal–organic framework (MOF)-derived CoPd nanoalloys have been prepared. The nanocatalysts exhibited excellent activities in the hydrogenation of nitroarenes and alkenes in green solvent (ethanol/water) under mild conditions (H2 balloon, room temperature). Using ZIF-67 as template for both carbon matrix and cobalt precursor coating with a mesoporous SiO2 layer, the catalyst CoPd/NC@SiO2 was smoothly constructed. Catalytic results revealed a synergistic effect between Co and Pd components in the hydrogenation process due to the enhanced electron density. The mesoporous SiO2 shell effectively prevented the sintering of hollow carbon and metal NPs at high temperature, furnishing the well-dispersed nanoalloy catalysts and better catalytic performance. Moreover, the catalyst was durable and showed negligible activity decay in recycling and scale-up experiments, providing a mild and highly efficient way to access amines and arenes.
Process for Synthesis of Chiral 3-Substituted Tetrahydroquinoline Derivatives
-
, (2015/02/19)
The present invention relates to novel and concise process for the construction of chiral 3-substituted tetrahyroquinoline derivatives based on proline catalyzed asymmetric α-functionalization of aldehyde, followed by in situ reductive cyclization of nitro group under catalytic hydrogenation condition with high optical purities. Further the invention relates to conversion of derived chiral 3-substituted tetrahydroquinoline derivatives into therapeutic agents namely (?)-sumanirole (96% ee) and 1-[(S)-3-(di-methylamino)-3,4-dihydro-6,7-dimethoxy-quinolin-1(2H)-yl]propanone[(S)-903] (92% ee).